Literature DB >> 16635443

The use of neurovascular imaging for triaging TIA and minor stroke: implications for therapy.

Andrew M Demchuk1.   

Abstract

Nondisabling cerebrovascular events (minor stroke or transient ischemic attack) are not benign; a significant proportion of these patients will suffer a new disabling stroke or develop stroke progression in hospital, resulting in dependence or death. With the exception of the modest benefits of aspirin, there are currently no effective acute medical therapies to prevent early progression or recurrence in such patients. Early carotid revascularization appears to be the most efficacious treatment available for patients with symptomatic (> 50%) internal carotid artery stenosis. More acute treatment and acute prevention trials are needed. MRI, CT bolus techniques, and transcranial Doppler emboli detection represent tools for detection of patients at high risk for deterioration and should be incorporated into the development of effective therapies by targeting the most appropriate patients for intervention.

Entities:  

Year:  2006        PMID: 16635443     DOI: 10.1007/s11936-006-0017-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  49 in total

1.  Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA.

Authors:  S A Josephson; S O Bryant; H K Mak; S C Johnston; W P Dillon; W S Smith
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

2.  Cost-effective investigation of patients with suspected transient ischaemic attacks.

Authors:  G J Hankey; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS).

Authors:  C S Kidwell; S Starkman; M Eckstein; K Weems; J L Saver
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

4.  Normal diffusion-weighted MRI during stroke-like deficits.

Authors:  H Ay; F S Buonanno; G Rordorf; P W Schaefer; L H Schwamm; O Wu; R G Gonzalez; K Yamada; G A Sorensen; W J Koroshetz
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions.

Authors:  Francisco Purroy; Joan Montaner; Alex Rovira; Pilar Delgado; Manuel Quintana; José Alvarez-Sabín
Journal:  Stroke       Date:  2004-08-19       Impact factor: 7.914

7.  Poststroke neurological improvement within 7 days is associated with subsequent deterioration.

Authors:  Stella Aslanyan; Christopher J Weir; S Claiborne Johnston; Kennedy R Lees
Journal:  Stroke       Date:  2004-07-08       Impact factor: 7.914

8.  Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease.

Authors:  Michael Eliasziw; James Kennedy; Michael D Hill; Alastair M Buchan; Henry J M Barnett
Journal:  CMAJ       Date:  2004-03-30       Impact factor: 8.262

9.  A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA.

Authors:  S Claiborne Johnston; Steve Sidney; Allan L Bernstein; Daryl R Gress
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

Authors:  P M Rothwell; A J Coull; M F Giles; S C Howard; L E Silver; L M Bull; S A Gutnikov; P Edwards; D Mant; C M Sackley; A Farmer; P A G Sandercock; M S Dennis; C P Warlow; J M Bamford; P Anslow
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.